Monitoring_VBG DPD_NN activity_NN may_MD be_VB important_JJ in_IN the_DT management_NN of_IN patients_NNS experiencing_VBG severe_JJ toxicity_NN secondary_JJ to_TO FUra_NN chemotherapy_NN ._.
The_DT putative_JJ intracellular_JJ receptors_NNS for_IN FK506_NN and_CC cyclosporin_NN are_VBP cis-trans_JJ prolyl_JJ isomerases_NNS ._.
Characterization_NN of_IN a_DT cofactor_NN that_WDT regulates_VBZ dimerization_NN of_IN a_DT mammalian_JJ homeodomain_NN protein_NN ._.
Regulation_NN of_IN replicative_JJ functions_NNS in_IN the_DT Epstein-Barr_JJ virus_NN EBV_NN genome_NN is_VBZ mediated_VBN through_IN activation_NN of_IN a_DT virally_RB encoded_VBN transcription_NN factor_NN ,_, Z_NN BZLF1_NN ._.
A_DT number_NN of_IN genes_NNS known_VBN to_TO be_VB induced_VBN following_VBG T_NN cell_NN activation_NN and_CC associated_VBN with_IN cell_NN growth_NN were_VBD increased_VBN in_IN the_DT transfectants_NNS ,_, including_VBG c-fos_NN ,_, c-myc_NN ,_, c-myb_NN ,_, HLA-DR_NN ,_, lck_NN ,_, NF-kappa_NN B_NN ,_, interleukin-2_NN and_CC interleukin-2_NN receptor_NN alpha_NN IL-2R_NN alpha_NN ._.
In_IN a_DT sample_NN from_IN one_CD of_IN the_DT patients_NNS ,_, c-fos-positive_JJ lymphocytes_NNS were_VBD identified_VBN as_IN CD4_NN positive_JJ and_CC CD8_NN negative_JJ ._.
Stability_NN of_IN the_DT c-fos_NN and_CC c-jun_NN mRNA_NN was_VBD not_RB affected_VBN by_IN LTB4_NN ,_, as_IN assessed_VBN after_IN actinomycin_NN D_NN treatment_NN ._.
We_PRP have_VBP demonstrated_VBN earlier_RBR that_IN the_DT crosslinkage_NN of_IN the_DT complex_NN with_IN the_DT CD2_NN antigen_NN results_VBZ in_IN the_DT proliferation_NN of_IN normal_JJ human_JJ T_NN cells_NNS ._.
Leukotriene_NN B4_NN stimulates_VBZ c-fos_NN and_CC c-jun_NN gene_NN transcription_NN and_CC AP-1_NN binding_NN activity_NN in_IN human_JJ monocytes_NNS ._.
However_RB ,_, in_IN normal_JJ subjects_NNS ,_, the_DT GR_NN in_IN MNL_NN did_VBD not_RB demonstrate_VB circadian_JJ variation_NN ,_, in_IN contrast_NN to_TO concentrations_NNS of_IN plasma_NN cortisol_NN ._.
Neither_CC Bt2cAMP_NN nor_CC PMA_NN individually_RB mediated_VBD these_DT sustained_JJ effects_NNS ,_, which_WDT therefore_RB appear_VBP as_IN a_DT consequence_NN of_IN the_DT interplay_NN between_IN both_DT metabolic_JJ stimuli_NNS ._.
Structurally_RB related_JJ divalent_JJ cations_NNS like_IN cobalt_NN ,_, nickel_NN ,_, and_CC mercury_NN also_RB partially_RB increase_VBP monokine_NN secretion_NN but_CC to_TO a_DT much_RB lower_JJR and_CC thus_RB insignificant_JJ extent_NN ._.
Nuclear_JJ transcription_NN studies_NNS in_FW vitro_FW showed_VBD that_IN LTB4_NN increased_VBD the_DT transcription_NN of_IN the_DT c-fos_NN gene_NN 7-fold_RB and_CC the_DT c-jun_NN gene_NN 1.4-fold_RB ._.
The_DT CD20_NN B1_NN gene_NN encodes_VBZ a_DT B_NN cell-specific_JJ protein_NN involved_VBN in_IN the_DT regulation_NN of_IN human_JJ B_NN cell_NN proliferation_NN and_CC differentiation_NN ._.
We_PRP showed_VBD that_IN both_CC IL-10_NN and_CC IL-4_NN inhibit_VBP LPS-induced_JJ IL-6_NN mRNA_NN and_CC protein_NN expression_NN by_IN inhibiting_VBG the_DT transcription_NN rate_NN of_IN the_DT IL-6_NN gene_NN ._.
To_TO determine_VB whether_IN specific_JJ members_NNS of_IN the_DT NF-kappa_NN B_NN family_NN contribute_VBP to_TO this_DT effect_NN ,_, we_PRP have_VBP examined_VBN the_DT abilities_NNS of_IN different_JJ NF-kappa_NN B_NN subunits_NNS to_TO act_VB with_IN Tat-I_NN to_TO stimulate_VB transcription_NN of_IN HIV_NN in_IN Jurkat_NN T-leukemia_NN cells_NNS ._.
There_EX is_VBZ a_DT suitably_RB located_JJ TATA_NN box_NN ,_, but_CC potential_JJ sites_NNS for_IN CCAAT-box_NN binding_NN factors_NNS are_VBP far_RB upstream_JJ ,_, embedded_JJ in_IN a_DT 42-nucleotide_JJ repeat_NN element_NN ._.
In_IN all_PDT the_DT subjects_NNS ,_, dexamethasone_NN was_VBD able_JJ to_TO suppress_VB plasma_NN cortisol_NN ._.
In_IN summary_NN ,_, we_PRP derived_VBD an_DT experimental_JJ system_NN that_WDT allows_VBZ us_PRP to_TO dissect_VB the_DT function_NN of_IN GATA-1_NN in_IN red_JJ cell_NN development_NN at_IN a_DT genetic_JJ level_NN ._.
These_DT results_NNS confirm_VBP at_IN a_DT molecular_JJ level_NN the_DT ability_NN of_IN HIV-1_NN to_TO replicate_VB in_IN B_NN cells_NNS and_CC that_IN this_DT activity_NN is_VBZ strongly_RB associated_VBN with_IN NF-kappaB_NN ._.
It_PRP is_VBZ located_JJ in_IN the_DT nucleus_NN in_IN mature_JJ B_NN cells_NNS ,_, but_CC is_VBZ present_JJ in_IN other_JJ cell_NN types_NNS as_IN an_DT inactive_JJ cytoplasmic_JJ complex_NN ._.
Although_IN ,_, the_DT level_NN of_IN MNDA_NN mRNA_NN in_IN primary_JJ monocytes_NNS is_VBZ very_RB low_JJ it_PRP was_VBD up-regulated_VBN at_IN 6_CD h_NN following_VBG the_DT addition_NN of_IN interferon_NN alpha_NN ._.
The_DT molecular_JJ background_NN of_IN the_DT defects_NNS in_IN the_DT immune_JJ reactivity_NN of_IN human_JJ neonates_NNS has_VBZ not_RB been_VBN fully_RB elucidated_VBN ._.
A_DT dominant_JJ inhibitory_JJ ras_NN mutant_NN specifically_RB blocked_VBD antigen_NN receptor_NN agonism_NN ,_, indicating_VBG that_IN ras_NN activity_NN is_VBZ required_VBN for_IN antigen_NN receptor_NN signaling_NN ._.
The_DT regulation_NN of_IN transcription_NN factors_NNS belonging_VBG to_TO the_DT signal_NN transducer_NN and_CC activator_NN of_IN transcription_NN STAT_NN family_NN was_VBD analyzed_VBN in_IN PHA-activated_JJ mononuclear_JJ cells_NNS and_CC in_IN purified_VBN T_NN cells_NNS activated_VBN by_IN cross-linking_JJ cell_NN surface_NN CD3_NN ._.